Home | Contact Us | Search
|
|
||
Home | Contact Us | Search |
|
||
|
|
|
|
 |
|
|
|
||||
|
|
||||
Genedata and Nonlinear Dynamics co-market solution for high-throughput protein-gel processing |
|||||
|
|||||
|
(Newcastle upon Tyne, UK and Basel, Switzerland) Nonlinear Dynamics Ltd, a leading provider of bioinformatics solutions, and Genedata AG, a global provider of computational solutions for drug discovery, announced today that they have entered a co-marketing agreement to promote synergies between their Progenesis and Expressionist solutions. Under the terms of the agreement, Nonlinear and Genedata are collaborating to create a more integrated workflow between these respective systems. "With this agreement we show our commitment to industrial-scale proteomics research", explained Adesh Kaul, head of the Expressionist business unit at Genedata AG. The combined solution delivers additional result validation preceding the final MS identification and sample classification stages of the gel-based workflow. Employing supplementary statistical processing to Progenesis 2D gel image analysis data, researchers are able to further corroborate findings and proceed to spot picking with greater confidence. "By automating the exchange of data between Progenesis and Expressionist, we are providing a high-throughput workflow for this otherwise time-consuming and error-prone task." John Spreadbury, Group Sales and Marketing Director at Nonlinear Dynamics and CEO of Nonlinear USA Inc., added, "This agreement has been demand led, with shared customers promoting to Genedata and Nonlinear the combined power of this integrated solution. We are always keen to talk to companies with whom we can broker these mutually beneficial arrangements, since it is in the end to the advantage of our customer base. We are looking forward to working with Genedata to help our customers achieve a greater body of statistical data with which to drive their proteomics research." About Genedata AGGenedata specializes in computational solutions for life science research, drug discovery, and drug development. The Company combines a comprehensive, scientifically validated computational platform with expert scientific consulting services to provide tailor-made solutions for specific applications and multiple therapeutic areas. Founded in 1997 as a spin-off from Novartis, the Company is privately held and has grown to an interdisciplinary, international team of dedicated experts. Genedata is headquartered in Basel (Switzerland) with subsidiaries and branch offices in Munich (Germany), San Francisco (USA), and Boston (USA). The Company is also represented by Infocom Corporation (Japan), DigiGenomics (Taiwan), and Research Instruments (Singapore, Malaysia). Contact: Tobe Freeman About Nonlinear Dynamics LtdNonlinear Dynamics develops proteomics analysis software that is different, ground-breaking and above all designed to help you generate reliable conclusions that are reproducible across labs. Our new way of thinking has been applied to LCMS, MALDI and 2D data analysis so you can make a real difference using a combination of the right techniques, your expertise and the Progenesis software. The TotalLab laboratory products for 1D gel analysis provide quick and simple quantitation through to in-depth lane relationship studies, as well as offering features for research that requires 21CFR part 11 compliance. "Everything about Nonlinear Dynamics makes it a great company to work with..." Nonlinear sells and supports its products through its UK headquarters and its USA office, as well as a global network of partners and OEM resellers. Contact: Beth Rossiter, Marketing Department Released: 20 October 2005 Current press releases | Archive press releases |
|||||
|
|
| © Nonlinear Dynamics Ltd. | Terms and Conditions | Trademarks | Privacy Policy |